- Home
- THR vs GLUE Comparison
THR vs GLUE Comparison
Compare THR & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THR | GLUE |
|---|---|---|
| Founded | 1954 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | THR | GLUE |
|---|---|---|
| Price | $40.22 | $16.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 380.8K | ★ 812.4K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.04 | N/A |
| EPS | ★ 1.75 | 0.25 |
| Revenue | ★ $509,054,000.00 | $181,538,000.00 |
| Revenue This Year | $4.87 | $81.52 |
| Revenue Next Year | $4.78 | N/A |
| P/E Ratio | ★ $22.93 | $64.61 |
| Revenue Growth | 3.08 | ★ 1112.27 |
| 52 Week Low | $23.05 | $3.50 |
| 52 Week High | $41.20 | $18.15 |
Technical Indicators
Market Signals| Indicator | THR | GLUE |
|---|---|---|
| Relative Strength Index (RSI) | 74.62 | 59.39 |
| Support Level | $38.01 | $15.21 |
| Resistance Level | $41.20 | $17.75 |
| Average True Range (ATR) | 1.47 | 0.98 |
| MACD | 0.30 | -0.10 |
| Stochastic Oscillator | 88.05 | 57.83 |
Price Performance
Historical ComparisonAbout THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
About GLUE Monte Rosa Therapeutics Inc.
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.